Leap Therapeutics Shares Jump on $59M Winklevoss-Led Crypto Deal

Shares of Leap Therapeutics (LPTX) climbed 25% after the microcap cancer drug developer announced a $58.9 million private investment led by Winklevoss Capital to kickstart a crypto treasury strategy. The investment, structured as a private placement, includes common shares and warrants priced at $0.61439 per unit. Winklevoss Capital, founded by Cameron and Tyler Winklevoss, will also gain two board seats at Leap. Exactly which cryptos would be purchased was not disclosed. Leap, known for its immuno-onco ...